Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylaxis vs On-demand Kogenate FS in Chinese Children with Hemophilia A
NCT01810666Phase 4Completed
- Sponsor
- Bayer
- Start
- Mar 2013
- Primary completion
- Jan 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of octocog alfa in hemophilia A, sponsored by Bayer. Started Mar 2013; status: completed.
02
Drugs
octocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT01810666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01810666.